Astra M. Liepa

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Charles S. Fuchs, Jiří Tomášek, Filip Dumitru et al. · The Lancet · 2013 · 2.2K citations · Full text

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +11

What Is Sufficient Evidence for the Reliability and Validity of Patient-Reported Outcome Measures?

Marlene H. Frost, Bryce B. Reeve, Astra M. Liepa et al. · Value in Health · 2007 · 549 citations · Full text

Reliability, Family Medicine, Health Policy +13

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

Wolfgang Wick, Vinay K. Puduvalli, Marc C. Chamberlain et al. · Journal of Clinical Oncology · 2010 · 507 citations

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet · 2017 · 175 citations · Full text

Platinum-based Therapy, Urology, Metastatic Urothelial Carcinoma +8

Health-Related Quality-of-Life Parameters as Independent Prognostic Factors in Advanced or Metastatic Bladder Cancer

D. Roychowdhury, A. Hayden, Astra M. Liepa · Journal of Clinical Oncology · 2003 · 119 citations